Orchid Ventures Stock Net Income

Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Orchid Ventures, as well as the relationship between them.
Orchid Ventures' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Orchid Ventures' valuation are provided below:
Orchid Ventures does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Search Suggestions

O Realty IncomeCompany
OCCIN OFS CreditCompany
OSCNX Oppenheimer Main StreetMutual Fund
OEF iShares SP 100ETF
OOI SP Global 100Index
OM MANTRACryptocurrency
OJUSX Orange JuiceCommodity
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Orchid Ventures reported net income of (3.15 Million). This is 100.92% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 100.55% higher than that of the company.

Orchid Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Orchid Ventures' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Orchid Ventures could also be used in its relative valuation, which is a method of valuing Orchid Ventures by comparing valuation metrics of similar companies.
Orchid Ventures is currently under evaluation in net income category among its peers.

Orchid Fundamentals

About Orchid Ventures Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Orchid Ventures's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orchid Ventures using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orchid Ventures based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Consideration for investing in Orchid Pink Sheet

If you are still planning to invest in Orchid Ventures check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orchid Ventures' history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities